Covid-fighting Winter Park firm expands arsenal with acquisition

A local biopharmaceutical firm’s efforts to develop treatments for diseases, including Covid-19, will get a shot in the arm after it bought another drug business. 

Cytocom Inc. purchased Frederick, Maryland-based ImQuest Life Sciences Inc. for an undisclosed amount, Cytocom announced July 20. The deal gives Winter Park-based Cytocom access to ImQuest employees and resources, including labs certified to test coronavirus, Cytocom CEO Michael Handley told OBJ via email. Read more here